Cargando…

A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality

OBJECTIVES: Causality assessment of adverse drug reactions (ADRs) by healthcare professionals is often informal which can lead to inconsistencies in practice. The Liverpool Causality Assessment Tool (LCAT) offers a systematic approach. An interactive, web‐based, e‐learning package, the Liverpool ADR...

Descripción completa

Detalles Bibliográficos
Autores principales: Conroy, Elizabeth J., Kirkham, Jamie J., Bellis, Jennifer R., Peak, Matthew, Smyth, Rosalind L., Williamson, Paula R., Pirmohamed, Munir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755231/
https://www.ncbi.nlm.nih.gov/pubmed/26032626
http://dx.doi.org/10.1111/ijpp.12197
_version_ 1782416171521277952
author Conroy, Elizabeth J.
Kirkham, Jamie J.
Bellis, Jennifer R.
Peak, Matthew
Smyth, Rosalind L.
Williamson, Paula R.
Pirmohamed, Munir
author_facet Conroy, Elizabeth J.
Kirkham, Jamie J.
Bellis, Jennifer R.
Peak, Matthew
Smyth, Rosalind L.
Williamson, Paula R.
Pirmohamed, Munir
author_sort Conroy, Elizabeth J.
collection PubMed
description OBJECTIVES: Causality assessment of adverse drug reactions (ADRs) by healthcare professionals is often informal which can lead to inconsistencies in practice. The Liverpool Causality Assessment Tool (LCAT) offers a systematic approach. An interactive, web‐based, e‐learning package, the Liverpool ADR Causality Assessment e‐learning Package (LACAeP), was designed to improve causality assessment using the LCAT. This study aimed to (1) get feedback on usability and usefulness on the LACAeP, identify areas for improvement and development, and generate data on effect size to inform a larger scale study; and (2) test the usability and usefulness of the LCAT. METHODS: A pilot, single‐blind, parallel‐group, randomised controlled trial hosted by the University of Liverpool was undertaken. Participants were paediatric medical trainees at specialty training level 1+ within the Mersey and North‐West England Deaneries. Participants were randomised (1 : 1) access to the LACAeP or no training. The primary efficacy outcome was score by correct classification, predefined by a multidisciplinary panel of experts. Following participation, feedback on both the LCAT and the LACAeP was obtained, via a built in survey, from participants. KEY FINDINGS: Of 57 randomised, 35 completed the study. Feedback was mainly positive although areas for improvement were identified. Seventy‐four per cent of participants found the LCAT easy to use and 78% found the LACAeP training useful. Sixty‐one per cent would be unlikely to recommend the training. Scores ranged from 4 to 13 out of 20. The LACAeP increased scores by 1.3, but this was not significant. CONCLUSIONS: Improving the LACAeP before testing it in an appropriately powered trial, informed by the differences observed, is required. Rigorous evaluation will enable a quality resource that will be of value in healthcare professional training.
format Online
Article
Text
id pubmed-4755231
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47552312016-02-25 A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality Conroy, Elizabeth J. Kirkham, Jamie J. Bellis, Jennifer R. Peak, Matthew Smyth, Rosalind L. Williamson, Paula R. Pirmohamed, Munir Int J Pharm Pract Research Papers OBJECTIVES: Causality assessment of adverse drug reactions (ADRs) by healthcare professionals is often informal which can lead to inconsistencies in practice. The Liverpool Causality Assessment Tool (LCAT) offers a systematic approach. An interactive, web‐based, e‐learning package, the Liverpool ADR Causality Assessment e‐learning Package (LACAeP), was designed to improve causality assessment using the LCAT. This study aimed to (1) get feedback on usability and usefulness on the LACAeP, identify areas for improvement and development, and generate data on effect size to inform a larger scale study; and (2) test the usability and usefulness of the LCAT. METHODS: A pilot, single‐blind, parallel‐group, randomised controlled trial hosted by the University of Liverpool was undertaken. Participants were paediatric medical trainees at specialty training level 1+ within the Mersey and North‐West England Deaneries. Participants were randomised (1 : 1) access to the LACAeP or no training. The primary efficacy outcome was score by correct classification, predefined by a multidisciplinary panel of experts. Following participation, feedback on both the LCAT and the LACAeP was obtained, via a built in survey, from participants. KEY FINDINGS: Of 57 randomised, 35 completed the study. Feedback was mainly positive although areas for improvement were identified. Seventy‐four per cent of participants found the LCAT easy to use and 78% found the LACAeP training useful. Sixty‐one per cent would be unlikely to recommend the training. Scores ranged from 4 to 13 out of 20. The LACAeP increased scores by 1.3, but this was not significant. CONCLUSIONS: Improving the LACAeP before testing it in an appropriately powered trial, informed by the differences observed, is required. Rigorous evaluation will enable a quality resource that will be of value in healthcare professional training. John Wiley and Sons Inc. 2015-05-29 2015-12 /pmc/articles/PMC4755231/ /pubmed/26032626 http://dx.doi.org/10.1111/ijpp.12197 Text en © 2015 The Authors. International Journal of Pharmacy Practice published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Papers
Conroy, Elizabeth J.
Kirkham, Jamie J.
Bellis, Jennifer R.
Peak, Matthew
Smyth, Rosalind L.
Williamson, Paula R.
Pirmohamed, Munir
A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality
title A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality
title_full A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality
title_fullStr A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality
title_full_unstemmed A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality
title_short A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality
title_sort pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755231/
https://www.ncbi.nlm.nih.gov/pubmed/26032626
http://dx.doi.org/10.1111/ijpp.12197
work_keys_str_mv AT conroyelizabethj apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT kirkhamjamiej apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT bellisjenniferr apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT peakmatthew apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT smythrosalindl apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT williamsonpaular apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT pirmohamedmunir apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT conroyelizabethj pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT kirkhamjamiej pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT bellisjenniferr pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT peakmatthew pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT smythrosalindl pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT williamsonpaular pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality
AT pirmohamedmunir pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality